BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6465021)

  • 1. Effects of nifedipine and verapamil on isometric and dynamic exercise in normal subjects.
    Stein DT; Lowenthal DT; Porter RS; Falkner B; Bravo EL; Hare TW
    Am J Cardiol; 1984 Aug; 54(3):386-9. PubMed ID: 6465021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two calcium blockers on hemodynamics, left ventricular mass, and coronary vasodilatory in advanced hypertension.
    Diamond JA; Krakoff LR; Goldman A; Coplan N; Gharavi A; Martin K; Goldsmith R; Henzlova MJ; Machac J; Phillips RA
    Am J Hypertens; 2001 Mar; 14(3):231-40. PubMed ID: 11281234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nifedipine on plasma catecholamines in man at rest and during exercise.
    Defer G; Guezennec YC; Lhoste F
    Eur J Clin Pharmacol; 1986; 30(6):727-9. PubMed ID: 3533568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divergent effects of verapamil and amlodipine at rest and during exercise.
    Joannides R; Moore N; Iacob M; Compagnon P; Bacri AM; Thuillez C
    J Hypertens Suppl; 1998 Jan; 16(1):S25-9. PubMed ID: 9534093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenergic activity and left ventricular function during treatment of essential hypertension with calcium antagonists.
    Muiesan G; Agabiti-Rosei E; Romanelli G; Muiesan ML; Castellano M; Beschi M
    Am J Cardiol; 1986 Feb; 57(7):44D-49D. PubMed ID: 3006466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic effects of calcium channel and beta-receptor antagonists: evaluation by Doppler echocardiography.
    Harrison MR; Clifton GD; DeMaria AN
    Am Heart J; 1991 Jan; 121(1 Pt 1):126-33. PubMed ID: 1670741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
    J Hypertens; 1998 Nov; 16(11):1357-69. PubMed ID: 9856375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
    J Hypertens; 1998 Sep; 16(9):1357-69. PubMed ID: 9746123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of nicardipine on the blood pressure at rest and on the pressor responses to cold, isometric exertion, and dynamic exercise in hypertensive patients.
    Taylor SH; Silke B; Ahuja RC; Okoli R
    J Cardiovasc Pharmacol; 1982; 4(5):803-7. PubMed ID: 6182412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in systemic and pulmonary vascular reactivity in hypertension following nifedipine and verapamil.
    Bailo M; Fiorentini C; Folli A; Galli C; Loaldi A; Maltagliati A; Tosi E; Tamborini G; Guazzi MD
    Angiology; 1987 Sep; 38(9):672-9. PubMed ID: 3310745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic effects of calcium channel blockers at rest and during exercise in essential hypertension.
    Lund-Johansen P
    Am J Med; 1985 Oct; 79(4A):11-8. PubMed ID: 4050841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the effects of nifedipine and verapamil on exercise performance in patients with mild to moderate hypertension.
    Halperin AK; Icenogle MV; Kapsner CO; Chick TW; Roehnert J; Murata GH
    Am J Hypertens; 1993 Dec; 6(12):1025-32. PubMed ID: 8136093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nifedipine or verapamil as sole treatment of hypertension. An intraarterial study.
    Gould BA; Hornung RS; Mann S; Subramanian VB; Raftery EB
    Hypertension; 1983; 5(4 Pt 2):II91-6. PubMed ID: 6862589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate-blood pressure product.
    White WB; Black HR; Weber MA; Elliott WJ; Bryzinski B; Fakouhi TD
    Am J Cardiol; 1998 Feb; 81(4):424-31. PubMed ID: 9485131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects on left ventricular performance of nifedipine and verapamil in exercise-induced angina pectoris.
    Silke B; Verma SP; Nelson GI; Ahuja RC; Hussain M; Taylor SH
    Br J Clin Pharmacol; 1984 Jun; 17(6):735-43. PubMed ID: 6743468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of cardiovascular, renal, and humoral effects of acute administration of two calcium channel blockers in normotensive and hypertensive subjects.
    Leonetti G; Cuspidi C; Sampieri L; Terzoli L; Zanchetti A
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S319-24. PubMed ID: 6184561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a role of inhibition of sympathetic neurotransmission in the cardiovascular effects of intravenously administered verapamil.
    Gurtu S; Mukerjee D; Shukla S
    Pharmacol Res; 1995 Jun; 31(6):383-6. PubMed ID: 8685077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of beta-adrenergic blockade on circulating catecholamines and dopamine-beta-hydroxylase activity during exercise in normal subjects.
    Sheehan MW; Brammell HL; Sable DL; Nies AS; Horwitz LD
    Am Heart J; 1983 May; 105(5):777-82. PubMed ID: 6303097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similarities and differences in the antihypertensive effect of two calcium antagonist drugs, verapamil and nifedipine.
    Agabiti-Rosei E; Muiesan ML; Romanelli G; Castellano M; Beschi M; Corea L; Muiesan G
    J Am Coll Cardiol; 1986 Apr; 7(4):916-24. PubMed ID: 3514729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sustained-release verapamil therapy on the blood pressure at rest and on the pressor response to isometric exertion in hypertensive patients.
    Cardillo C; Musumeci V; Savi L; Guardigli R; Mores N; Folli G
    Eur J Clin Pharmacol; 1988; 34(6):549-53. PubMed ID: 3169108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.